E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
16 / 06 / 2017

 


Analysis of completeness of drug package inserts available in India

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde.


Abstract
Background: Information about the drug used can be obtained from various sources of drug information. One of the easily available sources of drug information is package insert (PI). The PI is the primary source of drug information. The PI or leaflet is the leaflet containing information about the medicinal product which accompanies the medicinal product. A good PI contains the approved, essential, and accurate information and it contains information in a language that is not promotional, false, or misleading. It is evidence based and periodically updated. However, not all PIs conform to all the above standards. Hence, the present study was undertaken to evaluate the appropriateness of presently available drug PIs.

Aims and Objectives: The aim of this study is to evaluate the completeness of the presently available PIs and grade them.

Materials and Methods: The present study was cross-sectional, observational, prospective study. 55 PIs were collected from various pharmacies in request. Out of them, 5 were found to be duplicated and were rejected. Remaining 50 PIs were analyzed based on criteria laid under the Drugs and Cosmetics Rules 1945 under section 6.2 and 6.3 of schedule D.

Results: Among the 50 PIs, 35 (70%) were of Indian companies and 15 (30%) were of multinational companies. Furthermore, 31 (62%) were parenteral preparations, 15 (30%) were oral formulations, and 04 (8%) were topical preparations. PIs were inadequate as to retail price of drug (0%), references (14%), effect on ability to drive machines(26%), updated information, and provision of full information on request (38%). 52% of PIs were A category, 48% of PIs were B category, and none of PIs were C category.

Conclusions: The present study shows that there is still paucity of information and requirement of standardization of the presently available PIs, especially with regard to the size and shape of PIs, font size, references, effect on ability to drive machines, updated information, and provision of full information on request. Furthermore, PIs should be made mandatory with all medications.

Key words: Package Inserts; Drug Information; India; Patient Information Leaflets; Patient Information Package Inserts


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Nagaraja Prasad S
Articles by Shreenivas P Revankar
Articles by Vedavathi H
Articles by Harini Manjunath
Articles by Sriti Hegde
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde. Analysis of completeness of drug package inserts available in India. Natl J Physiol Pharm Pharmacol. 2017; 7(11): 1139-1143. doi:10.5455/njppp.2017.7.0519204062017


Web Style

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde. Analysis of completeness of drug package inserts available in India. https://www.njppp.com/?mno=267850 [Access: March 14, 2024]. doi:10.5455/njppp.2017.7.0519204062017


AMA (American Medical Association) Style

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde. Analysis of completeness of drug package inserts available in India. Natl J Physiol Pharm Pharmacol. 2017; 7(11): 1139-1143. doi:10.5455/njppp.2017.7.0519204062017



Vancouver/ICMJE Style

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde. Analysis of completeness of drug package inserts available in India. Natl J Physiol Pharm Pharmacol. (2017), [cited March 14, 2024]; 7(11): 1139-1143. doi:10.5455/njppp.2017.7.0519204062017



Harvard Style

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde (2017) Analysis of completeness of drug package inserts available in India. Natl J Physiol Pharm Pharmacol, 7 (11), 1139-1143. doi:10.5455/njppp.2017.7.0519204062017



Turabian Style

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde. 2017. Analysis of completeness of drug package inserts available in India. National Journal of Physiology, Pharmacy and Pharmacology, 7 (11), 1139-1143. doi:10.5455/njppp.2017.7.0519204062017



Chicago Style

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde. "Analysis of completeness of drug package inserts available in India." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 1139-1143. doi:10.5455/njppp.2017.7.0519204062017



MLA (The Modern Language Association) Style

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde. "Analysis of completeness of drug package inserts available in India." National Journal of Physiology, Pharmacy and Pharmacology 7.11 (2017), 1139-1143. Print. doi:10.5455/njppp.2017.7.0519204062017



APA (American Psychological Association) Style

Nagaraja Prasad S, Shreenivas P Revankar, Vedavathi H, Harini Manjunath, Sriti Hegde (2017) Analysis of completeness of drug package inserts available in India. National Journal of Physiology, Pharmacy and Pharmacology, 7 (11), 1139-1143. doi:10.5455/njppp.2017.7.0519204062017